Actinium Pharmaceuticals (ATNM) Current Leases (2019 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Current Leases of $8000.0 for Q1 2026, down 27.27% year-over-year from $11000.0 in Q1 2025, and down 98.87% quarter-over-quarter from $711000.0 in Q4 2025.
Actinium Pharmaceuticals (ATNM) Current Leases (2019 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Current Leases for 8 consecutive years, with $8000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 27.27% year-over-year to $8000.0; the TTM figure through Mar 2026 stood at $8000.0 (down 27.27% YoY), while the FY2025 annual figure was $711000.0, up 24.96% from the prior year.
- Current Leases eased to $8000.0 in Q1 2026 per ATNM's latest filing, from $711000.0 in the prior quarter.
- Across five years, Current Leases topped out at $711000.0 in Q4 2025 and bottomed at $1000.0 in Q3 2023.
- Historically, Current Leases has averaged $217117.6 across 5 years, with a median of $11000.0 in 2023.
- Annual changes were most pronounced in 2023 — Current Leases sank 99.74% — and 2024, when it jumped 26900.0%.
- Actinium Pharmaceuticals' Current Leases stood at $494000.0 in 2022, then slumped by 97.77% to $11000.0 in 2023, then jumped by 5072.73% to $569000.0 in 2024, then grew by 24.96% to $711000.0 in 2025, then plunged by 98.87% to $8000.0 in 2026.
- Business Quant data shows ATNM's Current Leases at $8000.0 in Q1 2026, $711000.0 in Q4 2025, and $11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Actinium Pharmaceuticals | 35.48 Mn | 35.48 Mn | - | 741,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 741,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 711,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 589,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 569,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 540,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 494,000.00 |
| Sep 30, 2022 | 386,000.00 |
| Jun 30, 2022 | 292,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 62,000.00 |
| Sep 30, 2021 | 84,000.00 |